Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 371

1.

Cutaneous leishmaniasis: progress towards a vaccine.

Launois P, Tacchini-Cottier F, Kieny MP.

Expert Rev Vaccines. 2008 Oct;7(8):1277-87. doi: 10.1586/14760584.7.8.1277. Review.

PMID:
18844599
[PubMed - indexed for MEDLINE]
2.

Recent advances in vaccines for leishmaniasis.

Requena JM, Iborra S, Carrión J, Alonso C, Soto M.

Expert Opin Biol Ther. 2004 Sep;4(9):1505-17. Review.

PMID:
15335317
[PubMed - indexed for MEDLINE]
3.

Progress towards a Leishmania vaccine.

Tabbara KS.

Saudi Med J. 2006 Jul;27(7):942-50. Review.

PMID:
16830009
[PubMed - indexed for MEDLINE]
4.

Vaccines and vaccination strategies against human cutaneous leishmaniasis.

Okwor I, Uzonna J.

Hum Vaccin. 2009 May;5(5):291-301. Epub 2009 May 12. Review.

PMID:
19221514
[PubMed - indexed for MEDLINE]
Free Article
5.

Vaccination against cutaneous leishmaniasis: current status.

Melby PC.

Am J Clin Dermatol. 2002;3(8):557-70. Review.

PMID:
12358557
[PubMed - indexed for MEDLINE]
6.

Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11.

Santos DM, Carneiro MW, de Moura TR, Fukutani K, Clarencio J, Soto M, Espuelas S, Brodskyn C, Barral A, Barral-Netto M, de Oliveira CI.

Int J Nanomedicine. 2012;7:2115-27. doi: 10.2147/IJN.S30093. Epub 2012 Apr 24.

PMID:
22619548
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.

Okwor I, Uzonna J.

Immunol Res. 2008;41(2):123-36. doi: 10.1007/s12026-008-8016-2. Review.

PMID:
18389179
[PubMed - indexed for MEDLINE]
8.
9.

DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.

Ahmed SB, Touihri L, Chtourou Y, Dellagi K, Bahloul C.

Vaccine. 2009 Jan 1;27(1):99-106. doi: 10.1016/j.vaccine.2008.10.013. Epub 2008 Oct 23.

PMID:
18951941
[PubMed - indexed for MEDLINE]
10.

Leishmania vaccines: progress and problems.

Kedzierski L, Zhu Y, Handman E.

Parasitology. 2006;133 Suppl:S87-112. Review.

PMID:
17274851
[PubMed - indexed for MEDLINE]
11.

Vaccine candidates for leishmaniasis: a review.

Nagill R, Kaur S.

Int Immunopharmacol. 2011 Oct;11(10):1464-88. doi: 10.1016/j.intimp.2011.05.008. Epub 2011 May 25. Review.

PMID:
21616175
[PubMed - indexed for MEDLINE]
12.

Innate immunity and Leishmania vaccination strategies.

Birnbaum R, Craft N.

Dermatol Clin. 2011 Jan;29(1):89-102. doi: 10.1016/j.det.2010.08.014. Review.

PMID:
21095533
[PubMed - indexed for MEDLINE]
13.

Vaccines in leishmaniasis: advances in the last five years.

Brodskyn C, de Oliveira CI, Barral A, Barral-Netto M.

Expert Rev Vaccines. 2003 Oct;2(5):705-17. Review.

PMID:
14711330
[PubMed - indexed for MEDLINE]
14.

Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections.

Zanin FH, Coelho EA, Tavares CA, Marques-da-Silva EA, Silva Costa MM, Rezende SA, Gazzinelli RT, Fernandes AP.

Microbes Infect. 2007 Jul;9(9):1070-7. Epub 2007 May 16.

PMID:
17644455
[PubMed - indexed for MEDLINE]
15.

Vaccination against Leishmania infections.

Mauël J.

Curr Drug Targets Immune Endocr Metabol Disord. 2002 Oct;2(3):201-26. Review.

PMID:
12476486
[PubMed - indexed for MEDLINE]
16.

Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals.

Khoshgoo N, Zahedifard F, Azizi H, Taslimi Y, Alonso MJ, Rafati S.

Vaccine. 2008 Oct 29;26(46):5822-9. doi: 10.1016/j.vaccine.2008.08.065. Epub 2008 Sep 18.

PMID:
18804512
[PubMed - indexed for MEDLINE]
17.

Vector transmission of leishmania abrogates vaccine-induced protective immunity.

Peters NC, Kimblin N, Secundino N, Kamhawi S, Lawyer P, Sacks DL.

PLoS Pathog. 2009 Jun;5(6):e1000484. doi: 10.1371/journal.ppat.1000484. Epub 2009 Jun 19.

PMID:
19543375
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice.

López-Fuertes L, Pérez-Jiménez E, Vila-Coro AJ, Sack F, Moreno S, Konig SA, Junghans C, Wittig B, Timón M, Esteban M.

Vaccine. 2002 Dec 13;21(3-4):247-57.

PMID:
12450700
[PubMed - indexed for MEDLINE]
19.

Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model.

Gomes R, Teixeira C, Teixeira MJ, Oliveira F, Menezes MJ, Silva C, de Oliveira CI, Miranda JC, Elnaiem DE, Kamhawi S, Valenzuela JG, Brodskyn CI.

Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7845-50. doi: 10.1073/pnas.0712153105. Epub 2008 May 28.

PMID:
18509051
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The immunology of Leishmania infection and the implications for vaccine development.

Vanloubbeeck Y, Jones DE.

Ann N Y Acad Sci. 2004 Oct;1026:267-72. Review.

PMID:
15604504
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk